Verrica Pharmaceuticals Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Verrica Pharmaceuticals Inc. (VRCA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$182.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $251.00K.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$433.00K.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.01M.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $2.09M.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $264.00K, a 76.60% decline from fiscal 2024.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.13M.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$587.00K, a 228.73% decline from fiscal 2022.
- Verrica Pharmaceuticals Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $456.00K, a 16.02% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$182.00K 10-Q · filed 2026-08-06 | -$1.19M derived: sum of 3 quarters · filed 2026-08-06 | $900.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$433.00K 10-Q · filed 2026-05-12 | -$1.45M derived: sum of 2 quarters · filed 2026-05-12 | $649.00K derived: sum of 3 quarters · filed 2026-05-12 | $377.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.08M derived: sum of 2 quarters · filed 2026-03-11 | $810.00K derived: sum of 3 quarters · filed 2026-08-06 | $264.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.82M derived: sum of 2 quarters · filed 2026-08-06 | $1.28M 10-Q · filed 2025-11-14 | $905.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$818.00K 10-Q · filed 2026-08-06 | -$1.19M derived: sum of 3 quarters · filed 2026-08-06 | -$1.30M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$546.00K 10-Q · filed 2026-05-12 | -$917.00K derived: sum of 2 quarters · filed 2026-05-12 | -$1.03M derived: sum of 3 quarters · filed 2026-05-12 | -$693.00K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$484.00K derived: sum of 2 quarters · filed 2026-03-11 | -$147.00K derived: sum of 3 quarters · filed 2026-03-11 | $1.13M 10-K · filed 2026-03-11 | |
| 2024-09-30 | -$113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $224.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.50M 10-Q · filed 2025-11-14 | $1.92M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.61M 10-Q · filed 2025-08-12 | $2.03M derived: sum of 3 quarters · filed 2025-08-12 | $3.92M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $1.27M 10-Q · filed 2025-05-13 | $1.70M derived: sum of 2 quarters · filed 2025-05-13 | $3.58M derived: sum of 3 quarters · filed 2025-05-13 | $1.95M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.30M derived: sum of 2 quarters · filed 2025-03-11 | $679.00K derived: sum of 3 quarters · filed 2025-03-11 | -$587.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $259.00K derived: sum of 2 quarters · filed 2024-11-05 | -$1.01M 10-Q · filed 2024-11-05 | -$287.00K derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.89M 10-Q · filed 2024-08-14 | -$2.17M derived: sum of 3 quarters · filed 2024-08-14 | -$1.39M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$1.27M 10-Q · filed 2024-05-13 | -$546.00K derived: sum of 2 quarters · filed 2024-05-13 | $238.00K derived: sum of 3 quarters · filed 2024-05-13 | -$273.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $720.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.50M derived: sum of 2 quarters · filed 2024-02-29 | $993.00K derived: sum of 3 quarters · filed 2024-02-29 | $456.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $784.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $273.00K derived: sum of 2 quarters · filed 2023-11-09 | -$264.00K 10-Q · filed 2023-11-09 | $46.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.05M 10-Q · filed 2023-08-08 | -$738.00K derived: sum of 3 quarters · filed 2023-08-08 | -$287.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$537.00K 10-Q · filed 2023-05-09 | -$227.00K derived: sum of 2 quarters · filed 2023-05-09 | $224.00K derived: sum of 3 quarters · filed 2023-05-09 | $19.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $761.00K derived: sum of 2 quarters · filed 2023-03-06 | $556.00K derived: sum of 3 quarters · filed 2023-03-06 | $543.00K 10-K · filed 2023-03-06 | |
| 2021-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $246.00K derived: sum of 2 quarters · filed 2022-11-07 | $233.00K 10-Q · filed 2022-11-07 | $310.00K derived: sum of 4 quarters · filed 2022-11-07 | |
| 2021-06-30 | -$205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$218.00K 10-Q · filed 2022-08-11 | -$141.00K derived: sum of 3 quarters · filed 2022-08-11 | -$1.71M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$13.00K 10-Q · filed 2022-05-09 | $64.00K derived: sum of 2 quarters · filed 2022-05-09 | -$1.51M derived: sum of 3 quarters · filed 2022-05-09 | -$98.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | -$1.50M derived: sum of 2 quarters · filed 2022-03-02 | -$85.00K derived: sum of 3 quarters · filed 2022-03-02 | -$786.00K 10-K · filed 2022-03-02 | |
| 2020-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$162.00K derived: sum of 2 quarters · filed 2021-11-12 | -$863.00K 10-Q · filed 2021-11-12 | -$873.00K 10-Q · filed 2020-11-09 | -$861.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $709.00K 10-Q · filed 2021-08-10 | $711.00K derived: sum of 3 quarters · filed 2021-08-10 | $2.69M derived: sum of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$701.00K 10-Q · filed 2021-05-07 | -$699.00K derived: sum of 2 quarters · filed 2021-05-07 | $1.28M derived: sum of 3 quarters · filed 2021-05-07 | $874.00K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $1.98M derived: sum of 2 quarters · filed 2021-03-17 | $1.57M derived: sum of 3 quarters · filed 2021-03-17 | $1.62M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.57M derived: sum of 2 quarters · filed 2020-11-09 | $1.62M 10-Q · filed 2020-11-09 | $1.25M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$404.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$358.00K 10-Q · filed 2020-08-05 | -$731.00K derived: sum of 3 quarters · filed 2020-08-05 | -$470.00K derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $46.00K 10-Q · filed 2020-05-07 | -$327.00K derived: sum of 2 quarters · filed 2020-05-07 | -$66.00K derived: sum of 3 quarters · filed 2020-05-07 | -$31.00K derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | -$373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$112.00K derived: sum of 2 quarters · filed 2020-03-13 | -$77.00K derived: sum of 3 quarters · filed 2020-03-13 | $923.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $296.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.30M 10-Q · filed 2019-11-06 | $1.17M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.03M 10-Q · filed 2019-08-07 | $907.00K derived: sum of 3 quarters · filed 2019-08-07 | $1.06M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-07 | $872.00K derived: sum of 2 quarters · filed 2019-05-07 | $1.03M derived: sum of 3 quarters · filed 2019-05-07 | ||
| 2017-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $28.00K derived: sum of 2 quarters · filed 2019-03-07 | $403.00K 10-K · filed 2019-03-07 | ||
| 2017-09-30 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $531.00K 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $375.00K 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |